The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | VIDA VIDA Global Inc. | TVP Bitcoin Venture GP II, L.L.C. owner | XIn-the-money exercise Series A Common Warrantsderivativeindirect: By TVP Bitcoin Venture Fund I, L.P. | -212,268 | $0.00 | $0 | 0 | 27 d ago |
| Sep 12, 2026 | CSHR CoinShares PLC | Daniel Masters director, owner | XIn-the-money exercise Ordinary Shares | +182,370 | - | - | 21,792,615 | 27 d ago |
| Sep 12, 2026 | CSHR CoinShares PLC | Daniel Masters director, owner | XIn-the-money exercise Call Option (right to buy)derivative | -1 | $0.00 | $0 | 0 | 27 d ago |
| Sep 9, 2026 | AQST Aquestive Therapeutics, Inc. | Peter E. Boyd Chief People Officer | XIn-the-money exercise Common Stock | +2,293 | $0.96 | $2,201 | 284,024 | 32 d ago |
| Sep 9, 2026 | AQST Aquestive Therapeutics, Inc. | Peter E. Boyd Chief People Officer | XIn-the-money exercise Warrant (Right to Buy)derivative | -2,293 | $0.00 | $0 | 0 | 32 d ago |
| Sep 4, 2026 | CNXU Conexeu Sciences Inc. | Lynn Sebastian Purcell director, owner | XIn-the-money exercise Common Stockindirect: By OnePointTwo Capital Ventures LLC | +217,608 | $2.30 | $500k | 2,951,848 | 33 d ago |
| Sep 4, 2026 | CNXU Conexeu Sciences Inc. | Lynn Sebastian Purcell director, owner | XIn-the-money exercise Warrantderivativeindirect: By OnePointTwo Capital Ventures LLC | -217,608 | $0.00 | $218 | 407,392 | 33 d ago |
| Sep 4, 2026 | CNXU Conexeu Sciences Inc. | Lynn Sebastian Purcell director, owner | XIn-the-money exercise Common Stockindirect: By OnePointTwo Capital Ventures LLC | +217,608 | $2.30 | $500k | 2,951,848 | 33 d ago |
| Sep 4, 2026 | CNXU Conexeu Sciences Inc. | Lynn Sebastian Purcell director, owner | XIn-the-money exercise Warrantderivativeindirect: By OnePointTwo Capital Ventures LLC | +217,608 | $0.00 | $218 | 407,392 | 33 d ago |
| Sep 8, 2026 | AQST Aquestive Therapeutics, Inc. | Daniel Barber President and CEO | XIn-the-money exercise Common Stock | +91,743 | $0.96 | $88k | 677,317 | 33 d ago |
| Sep 8, 2026 | AQST Aquestive Therapeutics, Inc. | Daniel Barber President and CEO | XIn-the-money exercise Warrant (Right to Buy)derivative | -91,743 | $0.00 | $0 | 0 | 33 d ago |
| Sep 4, 2026 | SPWR Complete Solaria, Inc. | Thurman J Rodgers Chief Executive Officer | XIn-the-money exercise Common Stockindirect: See note | +7,870,917 | $0.25 | $2.0M | 36,687,593 | 33 d ago |
| Sep 4, 2026 | SPWR Complete Solaria, Inc. | Thurman J Rodgers Chief Executive Officer | XIn-the-money exercise Simple Agreement for Future Equityderivativeindirect: See Footnote | - | $0.00 | - | - | 33 d ago |
| Sep 3, 2026 | AQST Aquestive Therapeutics, Inc. | Cassie Jung Chief Operating Officer | XIn-the-money exercise Common Stock | +4,587 | $0.96 | $4,404 | 206,833 | 34 d ago |
| Sep 3, 2026 | AQST Aquestive Therapeutics, Inc. | Cassie Jung Chief Operating Officer | XIn-the-money exercise Warrant (Right to Buy)derivative | -4,587 | $0.00 | $0 | 0 | 34 d ago |
| Sep 3, 2026 | GLIBA Liberty Capital Corp/NV | John C Malone director, owner | XIn-the-money exercise Put option (right to sell)derivative | -13,400 | $0.00 | $0 | 26,800 | 34 d ago |
| Sep 4, 2026 | GLIBA Liberty Capital Corp/NV | John C Malone director, owner | XIn-the-money exercise Put option (right to sell)derivative | -13,400 | $0.00 | $0 | 13,400 | 34 d ago |
| Sep 8, 2026 | GLIBA Liberty Capital Corp/NV | John C Malone director, owner | XIn-the-money exercise Put option (right to sell)derivative | -13,400 | $0.00 | $0 | 0 | 34 d ago |
| Aug 28, 2026 | CDT CONDUIT PHARMACEUTICALS INC. | Andrew Regan Chief Executive Officer | XIn-the-money exercise Pre-Funded Warrantsderivativeindirect: By Corvus Capital Ltd. | -5,436,830 | $0.00 | $544 | 0 | 40 d ago |
| Aug 31, 2026 | GLIBA Liberty Capital Corp/NV | John C Malone director, owner | XIn-the-money exercise Put option (right to sell)derivative | -13,400 | $0.00 | $0 | 67,000 | 40 d ago |
| Sep 1, 2026 | GLIBA Liberty Capital Corp/NV | John C Malone director, owner | XIn-the-money exercise Put option (right to sell)derivative | -13,400 | $0.00 | $0 | 53,600 | 40 d ago |
| Sep 2, 2026 | GLIBA Liberty Capital Corp/NV | John C Malone director, owner | XIn-the-money exercise Put option (right to sell)derivative | -13,400 | $0.00 | $0 | 40,200 | 40 d ago |
| Jun 20, 2025 | AEYE AUDIOEYE INC | James B Hawkins director | XIn-the-money exercise Common Stock | +1,000 | $16.00 | $16k | 129,916 | Jun 24, 2025 |
| Jun 20, 2025 | AEYE AUDIOEYE INC | James B Hawkins director | XIn-the-money exercise Common Stock | +7,600 | $15.00 | $114k | 137,516 | Jun 24, 2025 |
| Jun 20, 2025 | AEYE AUDIOEYE INC | James B Hawkins director | XIn-the-money exercise Put Option (obligation to buy)derivative | -10 | $0.00 | $0 | 0 | Jun 24, 2025 |
| Jun 20, 2025 | AEYE AUDIOEYE INC | James B Hawkins director | XIn-the-money exercise Put Option (obligation to buy)derivative | -76 | $0.00 | $0 | 0 | Jun 24, 2025 |
| Jun 20, 2025 | OTRK Ontrak, Inc. | Terren S Peizer owner | XIn-the-money exercise Common Stockindirect: By Humanitario | +500,000 | $0.00 | $700 | 2,305,480 | Jun 24, 2025 |
| Jun 20, 2025 | OTRK Ontrak, Inc. | Terren S Peizer owner | XIn-the-money exercise Pre-Funded Common Stock Purchase Warrantderivativeindirect: By Humanitario | -500,000 | $0.00 | $0 | 799,575 | Jun 24, 2025 |
| Jun 20, 2025 | KROS Keros Therapeutics, Inc. | ADAR1 Capital Management, LLC owner | XIn-the-money exercise Common Stockindirect: By ADAR1 Partners, LP | -100 | $60.00 | $6,000 | 4,392,637 | Jun 24, 2025 |
| Jun 20, 2025 | KROS Keros Therapeutics, Inc. | ADAR1 Capital Management, LLC owner | XIn-the-money exercise Common Stockindirect: By ADAR1 Partners, LP | -1,400 | $70.00 | $98k | 4,391,237 | Jun 24, 2025 |
| Jun 20, 2025 | KROS Keros Therapeutics, Inc. | ADAR1 Capital Management, LLC owner | XIn-the-money exercise Common Stockindirect: By Spearhead Insurance Solutions IDF, LLC | -200 | $70.00 | $14k | 743,358 | Jun 24, 2025 |
| Jun 20, 2025 | KROS Keros Therapeutics, Inc. | ADAR1 Capital Management, LLC owner | XIn-the-money exercise Put Option (right to sell)derivativeindirect: By ADAR1 Partners, LP | -1 | $0.00 | $0 | 0 | Jun 24, 2025 |
| Jun 20, 2025 | KROS Keros Therapeutics, Inc. | ADAR1 Capital Management, LLC owner | XIn-the-money exercise Put Option (right to sell)derivativeindirect: By ADAR1 Partners, LP | -14 | $0.00 | $0 | 0 | Jun 24, 2025 |
| Jun 20, 2025 | KROS Keros Therapeutics, Inc. | ADAR1 Capital Management, LLC owner | XIn-the-money exercise Put Option (right to sell)derivativeindirect: By Spearhead Insurance Solutions IDF, LLC | -2 | $0.00 | $0 | 0 | Jun 24, 2025 |
| Jun 20, 2025 | - BlackRock Direct Lending Corp. | Institution for Social Security Public owner | XIn-the-money exercise Common Stock, $0.001 par value | +2,084,925 | $9.58 | $20M | 29,076,852 | Jun 24, 2025 |
| Jun 20, 2025 | - BlackRock Direct Lending Corp. | Institution for Social Security Public owner | XIn-the-money exercise Obligation to Buyderivative | -2,084,925 | - | - | 0 | Jun 24, 2025 |
| Jun 17, 2025 | STLN Oncology Institute, Inc. | Richard A Barasch director | XIn-the-money exercise Common Stockindirect: By LLC | +679,224 | $1.20 | $814k | 3,234,765 | Jun 24, 2025 |
| Jun 17, 2025 | STLN Oncology Institute, Inc. | Richard A Barasch director | XIn-the-money exercise Common Warrantderivativeindirect: By LLC | -679,224 | $0.00 | $0 | 0 | Jun 24, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | TSSP Sub-Fund HoldCo LLC other | XIn-the-money exercise Common Stockindirect: Held by Barnett Equity Holdings, LLC | +2,255,048 | - | - | 3,976,063 | Jun 23, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | TSSP Sub-Fund HoldCo LLC other | XIn-the-money exercise Common Stockindirect: Held by Sixth Street Specialty Lending, Inc. | +118,687 | - | - | 1,129,212 | Jun 23, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | TSSP Sub-Fund HoldCo LLC other | XIn-the-money exercise Common Stockindirect: Held by Barnett Equity Holdings, LLC | +1,711,113 | - | - | 5,687,176 | Jun 23, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | TSSP Sub-Fund HoldCo LLC other | XIn-the-money exercise Common Stockindirect: Held by Sixth Street Specialty Lending, Inc. | +90,059 | - | - | 1,219,271 | Jun 23, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | TSSP Sub-Fund HoldCo LLC other | XIn-the-money exercise 2018 Warrantsderivativeindirect: Held by Barnett Equity Holdings, LLC | -13,009,892 | $0.00 | $0 | 0 | Jun 23, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | TSSP Sub-Fund HoldCo LLC other | XIn-the-money exercise 2018 Warrantsderivativeindirect: Held by Sixth Street Specialty Lending, Inc. | -684,731 | $0.00 | $0 | 0 | Jun 23, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | TSSP Sub-Fund HoldCo LLC other | XIn-the-money exercise 2020 Warrantsderivativeindirect: Held by Barnett Equity Holdings, LLC | -10,829,823 | $0.00 | $0 | 0 | Jun 23, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | TSSP Sub-Fund HoldCo LLC other | XIn-the-money exercise 2020 Warrantsderivativeindirect: Held by Sixth Street Specialty Lending, Inc. | -569,991 | $0.00 | $0 | 0 | Jun 23, 2025 |
| Jun 12, 2025 | AEYE AUDIOEYE INC | James B Hawkins director | XIn-the-money exercise Common Stock | +1,000 | $15.00 | $15k | 123,516 | Jun 17, 2025 |
| Jun 13, 2025 | AEYE AUDIOEYE INC | James B Hawkins director | XIn-the-money exercise Common Stock | +5,400 | $15.00 | $81k | 128,916 | Jun 17, 2025 |
| Jun 12, 2025 | AEYE AUDIOEYE INC | James B Hawkins director | XIn-the-money exercise Put Option (obligation to buy)derivative | -10 | $0.00 | $0 | 13,000 | Jun 17, 2025 |
| Jun 13, 2025 | AEYE AUDIOEYE INC | James B Hawkins director | XIn-the-money exercise Put Option (obligation to buy)derivative | -54 | $0.00 | $0 | 7,600 | Jun 17, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.